Belmont, CA, United States of America

David Y Jackson

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 99(Granted Patents)


Location History:

  • San Mateo, CA (US) (1997)
  • San Bruno, CA (US) (2002 - 2009)
  • Mountain View, CA (US) (2011)
  • Redwood City, CA (US) (2021 - 2022)
  • Belmont, CA (US) (2011 - 2024)

Company Filing History:


Years Active: 1997-2024

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Inventor Spotlight: David Y. Jackson

Introduction

David Y. Jackson, a prominent inventor based in Belmont, CA, has made significant contributions to the field of biomedical innovation. With a remarkable portfolio of 18 patents, his work primarily focuses on the development of modified antibodies, which hold great promise for treating various diseases, including cancer.

Latest Patents

Among his latest patents, Jackson has introduced groundbreaking inventions such as "Modified antibodies and related compounds, compositions and methods of use." This patent encompasses the creation of modified antibodies, the compounds necessary for their production, and the techniques involved in their synthesis. The implications of this research are profound, particularly in devising methods for treating diseases such as cancer in humans. Another notable invention is the "Antibody adjuvant conjugates," where Jackson outlines an immunoconjugate comprising an antibody construct, adjuvant moiety, and linker. This creation aids in enhancing the efficacy of cancer treatment by integrating adjuvants covalently bonded to antibodies.

Career Highlights

Throughout his esteemed career, David Y. Jackson has worked with leading organizations in the biotech field, including Genentech, Inc. and Leland Stanford Junior University. His positions in these institutions have not only allowed him to progress in his research but also to influence the direction of innovative therapeutic strategies.

Collaborations

Collaboration has been a cornerstone of Jackson’s success. He has worked alongside notable colleagues such as Daniel P. Sutherlin and Michael Nathaniel Alonso, combining their expertise to advance research in antibody technology and cancer therapies.

Conclusion

David Y. Jackson stands out as a leading figure in the world of biomedical innovation. With a dedication to improving healthcare through his patented inventions and collaborations with esteemed organizations and colleagues, he continues to pave the way for future advancements in the treatment of diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…